Search results
Memorial Day Movers: 3 Travel Stocks Poised for a Holiday Boost
InvestorPlace· 6 hours agoMemorial Day weekend signals the unofficial start of summer for most Americans. Meanwhile, on Wall...
Why Is MultiMetaVerse (MMV) Stock Up 105% Today?
InvestorPlace· 4 days agoThere are no new press releases or filings with the Securities and Exchange Commission (SEC) that explain why the stock is up today. This has more than...
Ginkgo Bioworks Stock Has 37.5% Downside, According to 1 Wall Street Analyst
Motley Fool via Yahoo Finance· 4 days agoTo me, that makes Ginkgo stock a sell. Should you invest $1,000 in Ginkgo Bioworks right now? Before...
7 Must-Buy Stocks if You Only Have $1,000 to Spend: May Edition
InvestorPlace· 2 days agoWith a modest $1,000 investment, you have ample dry powder to allocate into whichever stocks you...
Arcturus Therapeutics (NASDAQ:ARCT) Stock Price Up 5.8%
ETF DAILY NEWS· 11 hours agoArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) shares were up 5.8% during trading on Wednesday . The company traded as high as $31.59 and last traded at $31.59. Approximately ...
Why Medtronic Stock Slumped Today
Motley Fool via Yahoo Finance· 1 day agoConclusion: Medtronic stock clearly costs too much. That's why investors are selling. Should you invest $1,000 in Medtronic right now? Before you buy <...
$3.5M Bet On This Healthcare Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively...
Benzinga· 4 days agoOPK 10% owner Frost Gamma Investments Trust acquired a total of 163,997 shares at an average price...
Why Is Greenwave Technology Solutions (GWAV) Stock Down 60% Today?
InvestorPlace· 3 days agoGreenwave Technology Solutions (NASDAQ:GWAV) stock is falling on Tuesday after the metal recycling...
1 Growth Stock Down 62% to Buy Right Now
The Motley Fool via AOL· 4 days agoIf you're a risk-tolerant investor who believes in Toast's story, the reward potential right here and right now is worth the risk. Should you invest...
Arcturus Therapeutics’ (ARCT) Outperform Rating Reaffirmed at William Blair
ETF DAILY NEWS· 15 hours agoARCT has been the topic of a number of other research reports. Canaccord Genuity Group lowered their target price on shares of Arcturus Therapeutics from $87.00 to $86.00 and set a ...
